Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
IDXX holding history
IDEXX Laboratories Inc in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IDXX overviewAll 13F holders of IDXXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −397−100.0% | Sold out | Holders |
| Q1 2024 | 397 | $214.4K | 0.1% | −25−5.9% | Reduced | Holders |
| Q4 2023 | 422 | $234.2K | 0.1% | −38−8.3% | Reduced | Holders |
| Q3 2023 | 460 | $201.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 460 | $231.0K | 0.1% | −5−1.1% | Reduced | Holders |
| Q1 2023 | 465 | $232.5K | 0.1% | +465 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −490−100.0% | Sold out | Holders |
| Q1 2022 | 490 | $268.0K | 0.1% | −15−3.0% | Reduced | Holders |
| Q4 2021 | 505 | $314.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 505 | $314.0K | 0.1% | +505 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −510−100.0% | Sold out | Holders |
| Q1 2021 | 510 | $250.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.